The Bone & Joint Health Supplements Market is estimated to be valued at USD 11.7 billion in 2022. It is projected to reach USD 17.6 billion by 2027, recording a CAGR of 8.5% during the forecast period. The global bone & joint health supplements market has been influenced by some of the macroeconomic and microeconomic factors witnessed in some key countries. This would prove strong enough to drive the market significantly in terms of value sales during the forecast period. Growing demand for nutritional supplements like vitamin D, omega-3 fatty acids, calcium and collagen and several innovations in this sector fueling the demand for bone & joint health supplements market.
Asia pacific countries to record the fastest growth during the forecast period
The increase in the influence of westernization, the larger set of the millennial population, and the rise in awareness about the health benefits associated with the consumption of functional food products among Asian consumers are the key influential factors that drive demand for nutritional supplements of bone and joint health in the region. As a result, the millennials play an important role in the consumption of nutritional supplements for bone & joint health in the region that help them achieve the goal for optimal nutrition. Moreover, the global vegan market in the Asia Pacific region has been on the rise. There has been a rise in demand for plant-based food products, especially in India, China, Australia, and Indonesia, owing to the rise in awareness about the health benefits of consumption among consumers.
North America dominated the bone & joint health supplements market, with a value of USD 3,736.6 million in 2021; it is projected to reach USD 5,873.9 million by 2027, at a CAGR of 7.9% during the forecast period.
North America is one of the major consumers of bone & joint health supplements globally, owing to the high demand from elderly people population. Due to this, a few leading bone & joint health supplements manufacturers are established across this region, such as Procter & Gamble (US), Amway (US), Archer Daniels Midland (US), Reckitt Benckiser (UK), Pfizer (US), Arazo Nutrition (US), Nature’s Sunshine Products, Inc (US). Increasing aging population in the Asia Pacific region in countries such as Japan, China and India which are witnessing the higher growth in future for bone & joint health supplements. Hence, in terms of growth, it is expected that the Asia Pacific region would be growing at the highest rate, driven by the increasing awareness of bone & joint health with increasing aging population.
The key players in this market include Bayer AG(Germany), Procter & Gamble (US), Amway (US), Basf SE (Germany) and Archer Daniels Midland (US).
